Key Takeaways Labcorp targets growth through specialty testing in oncology, neurology and women's health. LH expanded with key acquisitions and partnerships to boost its national and clinical presence. Labcorp's solid balance sheet supports dividends and buybacks despite rising competitive pressure.Labcorp Holdings Inc. (LH) , or Labcorp’s strong focus on key areas such as oncology, women’s health, autoimmune disease and neurology is poised to help it grow in the upcoming quarters. The company maintains a ...